Imatinib Mesylate Tablet, Film Coated
Product Images NDC 42292-044

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Imatinib Mesylate (NDC 42292-044). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Imatinib Structural Formula (Image 01)

FDA Label Image

Imatinib Mesylate 100 mg Tablets Unit Carton Label (Image 02)

Imatinib Mesylate 100 mg Tablets Unit Carton Label (Image 02)
This is a description of Imatinib Mesylate Tablets which are available in a pack of three strips, each containing 10 tablets. The National Drug Code (NDC) for this medication is 42292-043-03. The tablets should be stored within a temperature range of 20°C to 25°C (68°F to 77°F), as specified by the United States Pharmacopeia (USP).*
FDA Label Image

Imatinib Mesylate 400 mg Tablets Unit Carton Label (Image 03)

Imatinib Mesylate 400 mg Tablets Unit Carton Label (Image 03)
This is a pharmaceutical product from Mylan, a company based in Rockford, USA. The container is not child-resistant and should be kept out of the reach of children. It provides light-resistance and the lot number and expiration date can be found on the window. It is intended for institutional use only.*
FDA Label Image

Figure 1: Progression Free Survival (itt Principle) (Image 04)

Figure 1: Progression Free Survival (itt Principle) (Image 04)
This appears to be a statistical table showing the number of patients with or without progression and discontinuation within a certain medical study or trial. The hazard ratio and log-rank test results are also given. A clear interpretation of these results is not possible without additional context.*
FDA Label Image

Figure 2: Time To Progression To Ap Or Bc (itt Principle) (Image 05)

FDA Label Image

Unit Carton (Image 06)

FDA Label Image

Unit Carton (Image 07)

Unit Carton (Image 07)
This is a medication package that does not have child-resistant features and is intended for institutional or adult use only. It is advised to keep this product out of reach of children. The package has light-resistant properties and the lot number and expiration date can be identified through a window. The product is manufactured by Mylan located in Rockford, IL.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.